Tyrosine kinase inhibitor CEP-701 blocks the NTRK1/NGF receptor and limits the invasive capability of prostate cancer cells in vitro.
about
NTRK1 fusion in glioblastoma multiformeTrkB is highly expressed in NSCLC and mediates BDNF-induced the activation of Pyk2 signaling and the invasion of A549 cells.Drug repurposing screen identifies lestaurtinib amplifies the ability of the poly (ADP-ribose) polymerase 1 inhibitor AG14361 to kill breast cancer associated gene-1 mutant and wild type breast cancer cells.Differential roles of Trk and p75 neurotrophin receptors in tumorigenesis and chemoresistance ex vivo and in vivo(R)-2-Phenylpyrrolidine Substituted Imidazopyridazines: A New Class of Potent and Selective Pan-TRK Inhibitors.NGF-induced TrkA/CD44 association is involved in tumor aggressiveness and resistance to lestaurtinib.Proliferation enhanced by NGF-NTRK1 signaling makes pancreatic cancer cells more sensitive to 2DG-induced apoptosis.Nerve growth factor in cancer cell death and survival.On Trk--the TrkB signal transduction pathway is an increasingly important target in cancer biology.Tropomyosin-receptor-kinases signaling in the nervous system.Entrectinib is a potent inhibitor of Trk-driven neuroblastomas in a xenograft mouse model.XPO1/CRM1-selective inhibitors of nuclear export (SINE) reduce tumor spreading and improve overall survival in preclinical models of prostate cancer (PCa).Discovery of GNF-5837, a Selective TRK Inhibitor with Efficacy in Rodent Cancer Tumor Models.Antitumor effects of saffron-derived carotenoids in prostate cancer cell models.Neurotrophic tyrosine kinase receptor 1 is a direct transcriptional and epigenetic target of IL-13 involved in allergic inflammation.BPH gene expression profile associated to prostate gland volumeTRAF4-mediated ubiquitination of NGF receptor TrkA regulates prostate cancer metastasis.Nerve Growth Factor (NGF)-Receptor Survival Axis in Head and Neck Squamous Cell Carcinoma.
P2860
Q28541127-3CB13015-B91A-4429-918B-ACD396AAA6A8Q33531352-E7BA89BF-FDD4-40D9-B5B5-E5BDC5759488Q34501206-4965F45B-0209-4D36-A9FF-D2C63F3FEF8FQ35042689-502FDD9F-753D-4821-B909-CE9B170A093FQ35615168-702DB7E1-6EAF-48BF-8B9F-CC322CC278AEQ35833152-9A327EB8-B664-46ED-864C-36538ADB9885Q36746869-60A210A1-662E-4190-82B3-DBE34813825CQ37129797-35AEF6C6-55F6-4B9A-8C2D-CEDEB27DAFB1Q37597739-EC4FD18C-61CD-4B58-925F-9D5ECC016F82Q38136198-74DED1D3-F78F-4401-B72E-804BF1E118C7Q38800617-4FA4FB93-60E8-4C5E-B582-98148ED430D4Q38950408-42925C51-50A2-44EA-93D4-2C43DA17B7BAQ39730920-9D58B73A-B8A1-4F9C-A22A-56D8CCFBD17FQ40029476-A13F9914-BDD2-408F-BB54-A3AA627062FDQ40590626-B4426419-FCA5-4EF0-9AEC-CCBF5FCE4E13Q42103664-645E75F0-9BAB-4691-9A96-BB694EC31D2EQ54979954-0BE1AA29-AC6B-4664-B549-634527C43F45Q55618544-33159238-468C-4B2D-A5BD-E6985538A2B0
P2860
Tyrosine kinase inhibitor CEP-701 blocks the NTRK1/NGF receptor and limits the invasive capability of prostate cancer cells in vitro.
description
2007 nî lūn-bûn
@nan
2007年の論文
@ja
2007年論文
@yue
2007年論文
@zh-hant
2007年論文
@zh-hk
2007年論文
@zh-mo
2007年論文
@zh-tw
2007年论文
@wuu
2007年论文
@zh
2007年论文
@zh-cn
name
Tyrosine kinase inhibitor CEP- ...... rostate cancer cells in vitro.
@en
type
label
Tyrosine kinase inhibitor CEP- ...... rostate cancer cells in vitro.
@en
prefLabel
Tyrosine kinase inhibitor CEP- ...... rostate cancer cells in vitro.
@en
P2093
P1476
Tyrosine kinase inhibitor CEP- ...... prostate cancer cells in vitro
@en
P2093
Carlo Vicentini
Claudio Festuccia
Danilo Millimaggi
Giovanni Luca Gravina
Mauro Bologna
Paola Muzi
Vincenza Dolo
P304
P577
2007-01-01T00:00:00Z